日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational study.

激活蛋白-1 (AP-1) 抑制可预防糖尿病相关动脉粥样硬化中的内皮细胞向间质细胞转化:一项转化研究。

Khan Abdul Waheed, Aziz Misbah, Sourris Karly C, Cortes Jairo P, Block Tomasz J, Dai Aozhi, Maxwell Scott, Okabe Jun, Pyper Emma, Paneni Francesco, Cooper Mark E, Jandeleit-Dahm Karin Am

Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney Disease.

脂氧素A4对VCAM-1的表观遗传调控可预防糖尿病肾病。

Bose Madhura, Mohan Muthukumar, Okabe Jun, Kaipananickal Harikrishnan, Priori Victoria, Chhor Carolyn, Sourris Karly C, Radman Ramtin, Tikellis Christos, Zhang Yvonne, El-Osta Assam, Brennan Eoin, Guiry Patrick J, Gahan Kevin, Tighe Catherine, Thomas Merlin, Jandeleit-Dahm Karin, Godson Catherine, Kantharidis Phillip, Cooper Mark E

Effects of empagliflozin on cardiac function and cardiorespiratory fitness in people with type 2 diabetes: a randomised controlled trial

恩格列净对2型糖尿病患者心脏功能和心肺功能的影响:一项随机对照试验

Nanayakkara, Natalie; Huang, Michael L H; La Gerche, Andre; Kaye, David M; Cooper, Mark E; Esler, Murray D; Reutens, Anne T; Shaw, Jonathan E; Jenkins, Alicia; Cohen, Neale D

GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity

GLP-1受体激动剂在治疗2型糖尿病和肥胖症合并慢性肾病中的应用

Cooper, Mark E; van Raalte, Daniël H

Proximal tubular deletion of superoxide dismutase-2 reveals disparate effects on kidney function in diabetes

近端肾小管超氧化物歧化酶-2缺失对糖尿病肾功能的影响各不相同

Trambas, Inez A; Bowen, Lilliana; Thallas-Bonke, Vicki; Snelson, Matthew; Sourris, Karly C; Laskowski, Adrienne; Tauc, Michel; Rubera, Isabelle; Zheng, Guoping; Harris, David C H; Kantharidis, Phillip; Shimizu, Takahiko; Cooper, Mark E; Tan, Sih Min; Coughlan, Melinda T

High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?

高密度脂蛋白对糖尿病肾病患者是利大于弊还是弊大于利?

Liu, Ke; Cooper, Mark E; Chai, Zhonglin; Liu, Fang

Induced Genetic Deletion of Cell Division Autoantigen 1 in Adulthood Attenuates Diabetes-Associated Renal Fibrosis

成年期诱导细胞分裂自身抗原1基因缺失可减轻糖尿病相关肾纤维化

Huynh, Pacific; Yang, Yuxin; Tian, Hua; Wu, Tieqiao; Huang, Minling; Tang, Jiali; Dai, Aozhi; Cooper, Mark E; Chai, Zhonglin

Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 Diabetes

恩格列净对2型糖尿病患者全身、心脏和肾脏交感神经输出的影响

Reutens, Anne T; Lekamlage, Dulari Hakamuwa; Salim, Agus; Shaw, Jonathan E; Esler, Murray D; Cooper, Mark E; Kaye, David M

Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials

利格列汀治疗中低血糖和心血管结局:CARMELINA 和 CAROLINA 试验的随机临床试验二次分析

Marx, Nikolaus; Kolkailah, Ahmed A; Rosenstock, Julio; Johansen, Odd Erik; Cooper, Mark E; Alexander, John H; Toto, Robert D; Wanner, Christoph; Espeland, Mark A; Mattheus, Michaela; Schnaidt, Sven; Perkovic, Vlado; Gollop, Nicholas D; McGuire, Darren K

Lipoxin A(4) improves cardiac remodeling and function in diabetes-associated cardiac dysfunction

脂氧素A4可改善糖尿病相关心脏功能障碍的心脏重塑和功能

Fu, Ting; Mohan, Muthukumar; Bose, Madhura; Brennan, Eoin P; Kiriazis, Helen; Deo, Minh; Nowell, Cameron J; Godson, Catherine; Cooper, Mark E; Zhao, Peishen; Kemp-Harper, Barbara K; Woodman, Owen L; Ritchie, Rebecca H; Kantharidis, Phillip; Qin, Cheng Xue